grant · US

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health

Forecast, not yet open. Dates may change.

AT A GLANCE

About this opportunity

National Institutes of Health lists this grant. The listed closing date is 25 May 2027. Check the official listing for details.

Who it’s for

Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); Small businesses; City or township governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); Private institutions of higher education; Public and State controlled institutions of higher education; State governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Special district governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments. Eligible applicants must be clinical trial sites that participate in a phase 2/3…

Explore related listings

General information only, not advice. Govlark lists public opportunities that look relevant to the description given; it does not assess eligibility and does not say you qualify. Always read the official listing and guidelines before applying.

Source: US Government work (public domain) · Source: Grants.gov · Report an error